Merck expands scope of Zymeworks antibody alliance, adding close to $900M in milestones
Nearly a decade after first partnering with Merck, Vancouver-based biotech Zymeworks has expanded its collaboration with the pharma giant once again.
Zymeworks re-upped with Merck …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
